Relationship between the nutritional status and safety and efficacy outcomes in atrial fibrillation patients aged 80 years and over receiving oral anticoagulants

被引:9
|
作者
Shinohara, Masaya [1 ]
Wada, Ryo [1 ]
Yano, Kensuke [1 ]
Akitsu, Katsuya [1 ]
Koike, Hideki [1 ]
Kinoshita, Toshio [1 ]
Fujino, Tadashi [1 ]
Ikeda, Takanori [1 ]
机构
[1] Toho Univ, Dept Cardiovasc Med, Fac Med, Tokyo, Japan
关键词
Nutritional status; Atrial fibrillation; Oral anticoagulants; SERUM-ALBUMIN; RISK; DEFINITION; WARFARIN; FRAILTY; STROKE; HEALTH; IMPACT; INDEX;
D O I
10.1016/j.jjcc.2020.10.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Malnutrition has been reported to be associated with worse clinical outcomes in various cardiovascular diseases. We aimed to investigate the clinical significance of the nutritional status in atrial fibrillation (AF) patients aged 80 years and over receiving oral anticoagulants (OACs), focusing on the difference between direct OACs (DOACs) and warfarin treatment. Methods: This was a retrospective and observational study. We enrolled 332 consecutive AF patients aged 80 years and over who were treated with OACs: DOACs (n = 256) and warfarin (n = 76). A controlling nutritional status (CONUT) score was used to evaluate the nutritional status. The enrolled patients were divided into two groups based on the CONUT score: CONUT score <5 (n = 239) and CONUT score >= 5 (n = 93) groups. We investigated the relationship between the nutritional status and clinical outcomes. Results: The CONUT score >= 5 group had significantly higher incidence of major bleeding (MB) compared to the CONUT score <5 group (4.6/100 person-years vs. 0.7/100 person-years, p < 0.01). On Cox hazard analysis, CONUT score >= 5 group was significantly associated with increased MB compared with the CONUT score <5 group (hazard ratio: 5.80, 95% confidence interval: 1.44-23.33, p = 0.013). In the DOAC group, the incidence of MB did not differ between the CONUT score >= 5 and CONUT score <5 groups (p = 0.54). In the warfarin group, MB occurred more frequently in the CONUT score >= 5 group than CONUT score <5 group (p < 0.01). There was no significant difference in the incidence of thromboembolic events between the CONUT score >= 5 and CONUT score <5 groups in both the DOAC and warfarin groups. Conclusions: The prognostic values of the nutritional status based on the CONUT score for MB differed between AF patients aged 80 years and over receiving DOACs and those receiving warfarin. It may be favorable to use DOACs to avoid bleeding events in those with malnutrition. (C) 2020 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:147 / 153
页数:7
相关论文
共 50 条
  • [21] The efficacy and safety of new oral anticoagulants in patients with atrial fibrillation in clinical practice
    Moiseev, S. V.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2016, 12 (02) : 220 - 226
  • [22] Anticoagulation in Patients Aged ≥75 years with Atrial Fibrillation: Role of Novel Oral Anticoagulants
    Ng K.H.
    Hart R.G.
    Eikelboom J.W.
    Cardiology and Therapy, 2013, 2 (2) : 135 - 149
  • [23] Novel Oral Anticoagulants and Atrial Fibrillation: Efficacy and Safety Considerations
    Apostolakis, Stavros
    DRUG DEVELOPMENT RESEARCH, 2013, 74 (08) : 505 - 509
  • [24] Effectiveness and Safety of Oral Anticoagulants in Patients with Atrial Fibrillation
    Lee, Chi-Yu
    Chang, Chen-Wang
    INTERNATIONAL JOURNAL OF GERONTOLOGY, 2023, 17 (01) : 1 - 1
  • [25] Gender Differences in Patients with Atrial Fibrillation Receiving Oral Anticoagulants
    Liao, Jo-Nan
    Huang, Yu-Shan
    Tsai, Chuan-Tsai
    Kuo, Ling
    Chen, Su-Jung
    Tuan, Ta-Chuan
    Chen, Tzeng-Ji
    Chen, Shih-Ann
    Chao, Tze-Fan
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2024, 25 (03)
  • [26] Clinical factors associated with safety and efficacy in patients receiving direct oral anticoagulants for non-valvular atrial fibrillation
    Yamato, Hiroshi
    Abe, Koichiro
    Osumi, Shun
    Yanagisawa, Daisuke
    Kodashima, Shinya
    Asaoka, Yoshinari
    Konno, Kumiko
    Kozuma, Ken
    Yamamoto, Takatsugu
    Tanaka, Atsushi
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [27] Clinical factors associated with safety and efficacy in patients receiving direct oral anticoagulants for non-valvular atrial fibrillation
    Hiroshi Yamato
    Koichiro Abe
    Shun Osumi
    Daisuke Yanagisawa
    Shinya Kodashima
    Yoshinari Asaoka
    Kumiko Konno
    Ken Kozuma
    Takatsugu Yamamoto
    Atsushi Tanaka
    Scientific Reports, 10
  • [28] Comparative Effectiveness and Safety of Oral Anticoagulants by Dementia Status in Older Patients With Atrial Fibrillation
    Lin, Kueiyu Joshua
    Singer, Daniel E.
    Bykov, Katsiaryna
    Bessette, Lily G.
    Mastrorilli, Julianna M.
    Cervone, Alexander
    Kim, Dae Hyun
    JAMA NETWORK OPEN, 2023, 6 (03)
  • [29] EFFICACY AND SAFETY OF DIRECT ORAL ANTICOAGULANTS AMONG MEDICARE PATIENTS WITH ATRIAL FIBRILLATION AND CANCER
    Chen, Sean
    Hellkamp, Anne
    Alhanti, Brooke
    Melloni, Chiara
    Piccini, Jonathan P., Sr.
    Khouri, Michel Georges
    Granger, Christopher B.
    Pokorney, Sean
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 113 - 113
  • [30] Consistency of Safety and Efficacy of New Oral Anticoagulants across Subgroups of Patients with Atrial Fibrillation
    Lega, Jean-Christophe
    Bertoletti, Laurent
    Gremillet, Cyrielle
    Chapelle, Celine
    Mismetti, Patrick
    Cucherat, Michel
    Vital-Durand, Denis
    Laporte, Silvy
    PLOS ONE, 2014, 9 (03):